ConvaTec Group (LON:CTEC) Sets New 52-Week Low – What’s Next?

Posted by Brian Himes on May 6th, 2026

ConvaTec Group PLC (LON:CTEC – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as GBX 206.20 and last traded at GBX 208.80, with a volume of 9914375 shares. The stock had previously closed at GBX 210.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Citigroup reiterated an “outperform” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, April 8th. Stifel Nicolaus reiterated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, March 11th. Berenberg Bank reiterated a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a research note on Tuesday, April 21st. Finally, Jefferies Financial Group reiterated a “buy” rating and set a GBX 325 target price on shares of ConvaTec Group in a research note on Friday, April 10th. Nine investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of GBX 319.67.

Read Our Latest Stock Analysis on CTEC

ConvaTec Group Price Performance

The company has a market cap of £4.22 billion, a price-to-earnings ratio of 25.12, a PEG ratio of 0.93 and a beta of 0.78. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19. The company’s 50 day moving average price is GBX 230.43 and its 200 day moving average price is GBX 233.91.

Insider Activity at ConvaTec Group

In other news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total value of £681,288.66. Company insiders own 0.95% of the company’s stock.

ConvaTec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.